Skip to main content

Table 5 Drugs sold to mystery shoppers, by programme status and type of outlet (in %)

From: Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya

Drugs sold Informed outlets Control outlets All outlets Signif.*
Shop/Kiosk ( n = 136 ) ( n = 238 ) ( n = 374 ) .000
SP 31.6 2.5 13.1  
AQ 28.7 33.2 31.6  
CQ 5.1 18.9 13.9  
Other anti-malarial 0.0 0.4 0.3  
Not an anti-malarial 5.9 6.7 6.4  
Not sold any drug 28.7 38.2 34.8  
Pharmacy/Chemist ( n = 54 ) ( n = 38 ) ( n = 92 ) .352
SP 24.1 23.7 23.9  
AQ 48.1 63.2 54.3  
CQ 20.4 10.5 16.3  
Other anti-malarial 0.0 0.0 0.0  
Not an anti-malarial 5.6 0.0 3.3  
Not sold any drug 1.9 2.6 2.2  
Private Clinic ( n = 12 ) ( n = 26 ) ( n = 38 ) .369
SP 16.7 3.8 7.9  
AQ 33.3 30.8 31.6  
CQ 8.3 26.9 21.1  
Other anti-malarial 0.0 7.7 5.3  
Not an anti-malarial 0.0 0.0 0.0  
Not sold any drug 41.7 30.8 34.2  
Total (n = 202) (n = 302) (n = 504) .000
SP 28.7 5.3 14.7  
AQ 34.2 36.8 35.7  
CQ 9.4 18.5 14.9  
Other anti-malarial 0.0 1.0 0.6  
Not an anti-malarial 5.4 5.3 5.3  
Not sold any drug 22.3 33.1 28.8  
  1. Notes: SP = sulfadoxine-pyrimethamine (recommended first-line drug); Amodiaquine (second-line drug only); Chloroquine (not recommended, to be sold by prescription only); Other anti-malarial (quinine, etc.); Not an anti-malarial (anti-pyretics or anti-biotics only). *Based on Pearson chi-square.